![Norbert Riedel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Norbert Riedel
Président chez
ETON PHARMACEUTICALS, INC.
Fortune : 11 M $ au 31/05/2026
Profil
Norbert G.
Riedel was the founder of Aptinyx, Inc., founded in 2015, where the title held was Executive Chairman from 2022 to 2023.
Current jobs include Director at Jazz Pharmaceuticals, Inc. since 2013; Director at Illinois Biotechnology Industry Organization since 2001; Director at Atsena Therapeutics, Inc.; Independent Director at Jazz Pharmaceuticals Plc since 2013; Director at TRACT Therapeutics, Inc.; Director at Cerevel Therapeutics LLC since 2018; Director at Illinois Biotechnology Innovation Organization; Director at Cerevel Therapeutics, Inc.; Operating Partner at Beecken Petty O'Keefe & Co. LP; Trustee at Chicago Symphony Orchestra Association; Member at Osterreichische Akademie Der Wissenschaften since 2009; Member-Supervisory Board at Zytoprotec GmbH; Adjunct Professor at Feinberg School of Medicine; Member at Austrian Academy of Sciences since 2009; Industry Advisor at Agent Capital LLC; and Chief Scientific Officer at Baxter Ventures.
Former jobs include President, Chief Executive Officer & Director at Naurex, Inc. from 2014 to 2015; Vice Chairman-Supervisory Board at MediGene AG from 2003 to 2013; Director at Oscient Pharmaceuticals Corp.
from 1999 to 2010; Independent Director at ARIAD Pharmaceuticals, Inc. from 2011 to 2017; Director at Genencor International, Inc.; Lead Independent Director at Cerevel Therapeutics Holdings, Inc. from 2018 to 2024; Chief Scientific & Innovation Officer at Baxter International, Inc. from 2011 to 2013; Principal at Hoechst AG; Vice President-Research & Development at Baxter BioScience Corp.
from 1998 to 2001; Head-Worldwide Biotechnology at Hoechst Marion Roussel, Inc. from 1996 to 1998; and Associate Professor at Boston University School of Medicine from 1987 to 1991.
Education includes undergraduate and doctorate degrees from Johann Wolfgang Goethe-Universität Frankfurt am Main, with the doctorate conferred in 1983.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/04/2026 | 224 300 ( 0,82 % ) | 7 M $ | 31/05/2026 | |
| 27/02/2026 | 17 654 ( 0,03 % ) | 4 M $ | 31/05/2026 |
Postes actifs de Norbert Riedel
| Sociétés | Poste | Début |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Directeur/Membre du Conseil | 13/05/2013 |
| ETON PHARMACEUTICALS, INC. | Président | 01/11/2018 |
Zytoprotec GmbH
 Zytoprotec GmbH Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for peritoneal dialysis | Directeur/Membre du Conseil | - |
Baxter Ventures
 Baxter Ventures Investment ManagersFinance Baxter Ventures invests in companies across the globe. The firm targets companies operating in the fields of medical devices, pharmaceutical and biotechnology companies sectors. It provides financing for early stage capital requirements and makes follow on investments. | Corporate Officer/Principal | - |
Beecken Petty O'Keefe & Co. LP
 Beecken Petty O'Keefe & Co. LP Investment ManagersFinance BPOC invests in middle - market companies located in the United States with an EBITDA of at least USD 3 million. The firm focuses on outsourced services, products & distribution, and pharmacy & pharma services sectors. It provides financing for buyout and growth stage capital requirements with an investment size ranging from USD 25 to 100 million. The firm acquires majority and minority investments and makes co-investments. | Private Equity Investor | - |
Cerevel Therapeutics, Inc.
 Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies | Directeur/Membre du Conseil | - |
Illinois Biotechnology Innovation Organization | Directeur/Membre du Conseil | - |
Agent Capital LLC
 Agent Capital LLC Investment ManagersFinance Agent Capital invests in companies located in the United States. The firm targets companies operating in the fields of therapeutics sectors and industries. It provides financing for seed, early, late stage, crossover and PIPE stage requirements. The firm acts as a lead investor and also makes co-investments. | Consultant / Advisor | - |
Feinberg School of Medicine
 Feinberg School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Norbert Riedel
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Norbert Riedel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
73
Relations au 1er degré
30
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 30 |
|---|---|
Baxter International, Inc.
 Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Markets and sells products to community-based primary care physicians | Commercial Services |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Hoechst AG
 Hoechst AG Chemicals: Major DiversifiedProcess Industries Produces specialty chemicals and pharmaceutical products | Process Industries |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Develops and manufactures enzyme product solutions | Health Technology |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Naurex, Inc.
 Naurex, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage company, which develops novel therapies | Health Technology |
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
Beecken Petty O'Keefe & Co. LP
Beecken Petty O'Keefe & Co. LP Investment ManagersFinance BPOC invests in middle - market companies located in the United States with an EBITDA of at least USD 3 million. The firm focuses on outsourced services, products & distribution, and pharmacy & pharma services sectors. It provides financing for buyout and growth stage capital requirements with an investment size ranging from USD 25 to 100 million. The firm acquires majority and minority investments and makes co-investments. | Finance |
Johann Wolfgang Goethe-Universität Frankfurt am Main
 Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chicago Symphony Orchestra Association
 Chicago Symphony Orchestra Association Movies/EntertainmentConsumer Services Operates music bands and orchestra | Consumer Services |
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Health Technology |
Hoechst Marion Roussel, Inc.
 Hoechst Marion Roussel, Inc. Pharmaceuticals: GenericHealth Technology Develops, manufactures and sells generic pharmaceutical products | Health Technology |
Illinois Biotechnology Industry Organization
 Illinois Biotechnology Industry Organization Miscellaneous Commercial ServicesCommercial Services Life science industry association | Commercial Services |
Osterreichische Akademie Der Wissenschaften | |
Jazz Pharmaceuticals Plc
 Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Baxter Ventures
Baxter Ventures Investment ManagersFinance Baxter Ventures invests in companies across the globe. The firm targets companies operating in the fields of medical devices, pharmaceutical and biotechnology companies sectors. It provides financing for early stage capital requirements and makes follow on investments. | Finance |
Zytoprotec GmbH
Zytoprotec GmbH Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for peritoneal dialysis | Health Technology |
Feinberg School of Medicine
Feinberg School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Medicine
 Boston University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aptinyx, Inc.
 Aptinyx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies to treat disorders of the brain and nervous system | Health Technology |
Austrian Academy of Sciences
 Austrian Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Provides humanities and social science research services | Commercial Services |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital invests in companies located in the United States. The firm targets companies operating in the fields of therapeutics sectors and industries. It provides financing for seed, early, late stage, crossover and PIPE stage requirements. The firm acts as a lead investor and also makes co-investments. | Finance |
Eton Pharmaceuticals, Inc.
 Eton Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes prescription drug products | Health Technology |
TRACT Therapeutics, Inc.
 TRACT Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops revolutionary therapeutic cells | Commercial Services |
Cerevel Therapeutics LLC
 Cerevel Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops drugs to treat disorders of central nervous system | Health Technology |
Atsena Therapeutics, Inc.
 Atsena Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical-stage gene therapy company that develops treatments for inherited retinal diseases that cause blindness | Health Technology |
Cerevel Therapeutics Holdings, Inc.
 Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies | Health Technology |
Illinois Biotechnology Innovation Organization |
